McCullough David 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jan 25, 2010
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2010-01-22$7.02/sh−14,271$100,182→ 5,626 total
Footnotes (1)
- [F1]Transacted under a 10b5-1 plan that was adopted on 12/14/09.